A cup of cooked lentils costs about 25 cents, keeps for years in a pantry, and now carries some of the strongest observational evidence in nutrition for lowering the odds of developing high blood pressure. A meta-analysis of 12 prospective cohort studies, published in May 2026 in BMJ Nutrition, Prevention & Health, found that people who eat the most legumes and soy foods face roughly 30 percent lower odds of developing hypertension than those who eat the least. The foods in question are not high-tech supplements. They are beans, lentils, chickpeas, and tofu.
What the meta-analysis actually measured
Researchers pooled data from 12 long-term cohort studies that tracked legume and soy intake alongside new diagnoses of high blood pressure. In the simplest comparison, people in the highest consumption group had a relative risk of about 0.84 compared with the lowest group, translating to a 16 percent reduction. For soy foods specifically, the relative risk fell to roughly 0.81, or a 19 percent reduction.
The larger numbers came from dose-response modeling, which estimates risk at specific intake levels rather than just comparing top and bottom categories. At approximately 170 grams per day of legumes (just under one cup of cooked lentils or black beans), the estimated risk reduction reached about 30 percent. For soy products like tofu, an intake of roughly 60 to 80 grams per day, about the size of a small deck of cards, was linked to a 28 to 29 percent reduction.
Those figures have drawn attention because they sit in the same neighborhood as the relative risk reductions seen with some first-line blood pressure medications in mild hypertension. But the comparison demands caution: drug trials measure absolute drops in blood pressure (typically 8 to 10 mmHg for common medications like ACE inhibitors), while this meta-analysis reports relative risk of developing hypertension over years. The two metrics answer different questions, and equating them overstates what observational nutrition data can prove.
The studies behind the numbers
Several independent datasets reinforce the pattern. The Multi-Ethnic Study of Atherosclerosis (MESA) tracked roughly 2,294 adults without baseline hypertension for up to 18 years, using a 120-item food frequency questionnaire. MESA defined incident hypertension as systolic blood pressure at or above 130, diastolic at or above 80, or new use of blood pressure medication. These MESA findings on plant protein and hypertension were reported within the pooled studies included in the BMJ meta-analysis; specific publication details for the MESA cohort results should be confirmed through the meta-analysis reference list. Across a racially and ethnically diverse U.S. sample, higher plant protein intake was inversely associated with new hypertension diagnoses.
The EPIC-Norfolk cohort, drawn from a Western European population, used seven-day food diaries instead of recall-based questionnaires. That distinction matters. Food diaries capture what people eat in real time and reduce the recall bias that critics routinely flag in nutrition research. EPIC-Norfolk also found a protective association between legume consumption and blood pressure outcomes, adding geographic and methodological diversity to the evidence.
Earlier intervention evidence from the PREMIER study, a randomized trial, showed that higher plant protein intake was inversely associated with blood pressure in a controlled clinical setting. PREMIER measured blood pressure change over months rather than long-term hypertension incidence, but it provided a mechanistic bridge: when participants shifted toward plant protein, their blood pressure readings dropped within the study period.
An older systematic review covering 12 food groups had already flagged an inverse association between legumes and hypertension risk, giving the new BMJ analysis a consistent historical backdrop. Taken together, these lines of evidence show that across varied populations, dietary tools, and study designs, higher legume and soy consumption repeatedly tracks with lower blood pressure or lower odds of developing hypertension.
A dietitian’s lens on the data
Registered dietitians who specialize in cardiovascular nutrition have generally welcomed the findings while urging patients not to overinterpret them. The consensus among nutrition professionals is that legumes and soy foods are already recommended as part of heart-healthy eating patterns such as the DASH diet and the Mediterranean diet, and this meta-analysis strengthens the case rather than breaking entirely new ground. Dietitians also stress that the benefit likely comes from the whole dietary context: someone adding lentils to a plate already rich in vegetables, whole grains, and healthy fats will probably see more benefit than someone adding a scoop of beans to an otherwise sodium-heavy, ultra-processed diet. The practical advice from clinical nutrition experts remains consistent: aim for variety, watch sodium during preparation, and treat legumes as one component of a broader pattern rather than a standalone fix.
Where the evidence has gaps
The 30 percent figure, while striking, rests on food frequency questionnaires and food diaries, not controlled feeding studies where researchers dictate every meal. None of the included cohorts measured plasma amino acid levels, gut microbiome composition, or other biomarkers that could explain the mechanism. Without those data, it remains unclear whether the benefit comes from the protein itself, the fiber, the potassium, the magnesium, the displacement of sodium-heavy processed foods, or some combination of all of these.
Preparation methods are another blind spot. A can of chickpeas rinsed and tossed into a salad carries a different sodium load than chickpeas simmered for hours in salted broth. The studies did not break down how participants cooked or seasoned their legumes, so the dose-response curves reflect total grams consumed without accounting for added sodium or fat. Someone eating heavily salted refried beans and someone eating unsalted lentil soup could look identical in the dataset despite very different cardiovascular risk profiles.
The target intake of 170 grams per day is also well above what most Americans currently eat. USDA data consistently show that average U.S. legume consumption falls far short of that level. Whether large populations can sustain that intake over years, and whether the benefit holds at lower but still increased levels, has not been tested in a long-term randomized trial.
Confounding is the perennial concern with observational nutrition research. People who eat a cup of lentils daily tend to differ from those who never touch legumes in ways that extend well beyond diet: exercise habits, income, healthcare access, and overall dietary quality all cluster together. The meta-analysis used statistical adjustments, but no adjustment can fully eliminate unmeasured confounders.
Finally, most of the cohorts came from high-income countries with relatively stable food supplies. How well these findings apply to regions where legumes are already staple foods but healthcare systems are more fragmented, or where baseline sodium intake is extremely high, remains an open question.
What this looks like on a plate
For individuals, the findings do not mean that eating a bowl of lentils guarantees protection from high blood pressure, or that anyone should swap their prescribed medication for a bag of chickpeas. What the data suggest is that regularly including beans, lentils, chickpeas, and soy foods as part of an overall healthy eating pattern may meaningfully lower risk over time, particularly when combined with other proven measures: limiting sodium, staying physically active, and maintaining a healthy weight.
The intake levels tied to the largest benefit translate to realistic meals. A cup of bean chili at lunch, a side of lentil salad at dinner, or a tofu stir-fry a few times a week can move a person closer to the ranges seen in the dose-response models. For people who rarely eat legumes, gradual increases tend to be more comfortable, giving the digestive system time to adjust to the higher fiber load and reducing the bloating and gas that discourage many first-time legume eaters from sticking with the habit.
From a public health perspective, the results align with existing dietary guidelines from the American Heart Association and the World Health Organization, both of which encourage replacing some animal protein with plant protein. Because legumes are inexpensive, shelf-stable, and widely available, they offer a practical lever for population-level strategies aimed at curbing rising hypertension rates. Policies that make these foods easier to access and prepare, such as expanding legume-based options in school and workplace cafeterias, could amplify the benefits observed in the cohort data.
Why researchers are now chasing mechanisms and feasibility trials
The next wave of studies will likely focus on mechanisms and feasibility. Future trials may pair detailed dietary tracking with biomarker analysis, microbiome profiling, and continuous blood pressure monitoring to pin down exactly how legumes and soy exert their effects. Researchers also want to know whether the benefit plateaus at a certain intake level or continues to grow, and whether specific legume types (black beans versus kidney beans versus lentils, for example) differ in their impact.
Until those data arrive, the current evidence offers a clear, low-risk signal: building meals around beans, lentils, chickpeas, and tofu is unlikely to cause harm and quite possibly helps keep blood pressure in a healthier range. For clinicians and patients searching for food-based strategies to complement standard care, legumes and soy foods now carry some of the strongest observational support in the hypertension literature. The prescription, if you can call it that, is already sitting in the pantry.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
